Zhengye Biotechnology (ZYBT) vice general manager files initial Form 3
Rhea-AI Filing Summary
Zhengye Biotechnology Holding Ltd filed an initial insider ownership report for Vice General Manager Cheng Yuhong on Form 3. This filing identifies Cheng as an officer of the company but shows no reported transactions, no derivative positions, and no current holdings entries at the time of this statement.
Positive
- None.
Negative
- None.
Key Figures
Buy transactions: 0 shares
Sell transactions: 0 shares
Derivative exercises: 0 shares
+2 more
5 metrics
Buy transactions
0 shares
buyShares in transactionSummary
Sell transactions
0 shares
sellShares in transactionSummary
Derivative exercises
0 shares
exerciseShares in transactionSummary
Holdings entries
0
holdingEntries in transactionSummary
Net buy/sell direction
neutral
netBuySellDirection in transactionSummary
Key Terms
Form 3, reporting person, derivative securities
3 terms
Form 3 regulatory
"Initial statement of beneficial ownership reported on Form 3."
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
reporting person regulatory
"The reporting person is listed as Vice General Manager."
derivative securities financial
"No derivative securities appear in the derivativeSummary section."
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Zhengye Biotechnology (ZYBT) disclose in this Form 3 filing?
Zhengye Biotechnology reports an initial insider ownership statement for Vice General Manager Cheng Yuhong. The filing lists Cheng as an officer but shows no reported holdings, transactions, or derivative positions in the summarized data at the time of the report.
Who is the reporting person in Zhengye Biotechnology’s ZYBT Form 3?
The reporting person is Cheng Yuhong, identified as Vice General Manager of Zhengye Biotechnology Holding Ltd. Cheng is treated as an officer for insider reporting purposes, triggering the requirement to file this initial statement of beneficial ownership on Form 3.
Does the ZYBT Form 3 show any insider buying or selling activity?
No insider buying or selling is shown in the summarized Form 3 data. BuyCount, SellCount, and NetBuySellShares are all zero, indicating no reported open-market purchases, sales, or net share changes in this initial ownership statement.
Are there any derivative securities reported for Cheng Yuhong in ZYBT’s Form 3?
No derivative securities are reported for Cheng Yuhong in this Form 3. The derivativeSummary is empty and derivativeTransactionCount is zero, indicating no listed options, warrants, or other derivative positions in this initial insider ownership disclosure.
What does a holdingEntries value of zero mean in the ZYBT Form 3?
A holdingEntries value of zero means no specific security holdings are itemized in this Form 3 summary. The filing establishes Cheng Yuhong as a reportable officer but does not list individual equity positions or share counts in the provided structured data.